AU746153B2 - Method for tissue perfusion - Google Patents

Method for tissue perfusion Download PDF

Info

Publication number
AU746153B2
AU746153B2 AU20245/99A AU2024599A AU746153B2 AU 746153 B2 AU746153 B2 AU 746153B2 AU 20245/99 A AU20245/99 A AU 20245/99A AU 2024599 A AU2024599 A AU 2024599A AU 746153 B2 AU746153 B2 AU 746153B2
Authority
AU
Australia
Prior art keywords
tissue
active agent
solution
normal
volume
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU20245/99A
Other languages
English (en)
Other versions
AU2024599A (en
Inventor
Vincent Decrescito
Richard Kronenthal
Dean Mcbeth
Dennis Pietronigro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Direct Therapeutics Inc
Original Assignee
Direct Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Direct Therapeutics Inc filed Critical Direct Therapeutics Inc
Publication of AU2024599A publication Critical patent/AU2024599A/en
Application granted granted Critical
Publication of AU746153B2 publication Critical patent/AU746153B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU20245/99A 1997-12-31 1998-12-31 Method for tissue perfusion Ceased AU746153B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7017597P 1997-12-31 1997-12-31
US60/070175 1997-12-31
PCT/US1998/027926 WO1999033492A1 (en) 1997-12-31 1998-12-31 Method for tissue perfusion

Publications (2)

Publication Number Publication Date
AU2024599A AU2024599A (en) 1999-07-19
AU746153B2 true AU746153B2 (en) 2002-04-18

Family

ID=22093614

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20245/99A Ceased AU746153B2 (en) 1997-12-31 1998-12-31 Method for tissue perfusion

Country Status (5)

Country Link
EP (1) EP1042004A4 (de)
JP (1) JP2001527051A (de)
AU (1) AU746153B2 (de)
CA (1) CA2315092A1 (de)
WO (1) WO1999033492A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10111486A1 (de) * 2001-03-09 2002-10-02 Ralph R Dawirs Verwendung einer oder mehrerer neuroaktiver Substanzen zur Behandlung der Parkinsonschen Krankheit
WO2009002273A1 (en) 2007-06-26 2008-12-31 Agency For Science, Technology And Research Imaging chamber with window and micro-needle platform magnetically biased toward each other

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5851527A (en) * 1988-04-18 1998-12-22 Immunomedics, Inc. Method for antibody targeting of therapeutic agents
US5162115A (en) * 1989-05-09 1992-11-10 Pietronigro Dennis D Antineoplastic solution and method for treating neoplasms
US5051257A (en) * 1989-05-09 1991-09-24 Pietronigro Dennis D Antineoplastic solution and method for treating neoplasms

Also Published As

Publication number Publication date
WO1999033492A9 (en) 1999-09-30
AU2024599A (en) 1999-07-19
EP1042004A1 (de) 2000-10-11
WO1999033492A1 (en) 1999-07-08
CA2315092A1 (en) 1999-07-08
JP2001527051A (ja) 2001-12-25
EP1042004A4 (de) 2004-08-25

Similar Documents

Publication Publication Date Title
Lonser et al. Successful and safe perfusion of the primate brainstem: in vivo magnetic resonance imaging of macromolecular distribution during infusion
US6652884B2 (en) Method for the treatment of solid tumors by albumin microparticles incorporating paclitaxel
Turner et al. Administration of substances to laboratory animals: routes of administration and factors to consider
US9149537B2 (en) Compositions and methods for the treatment of traumatic brain injury
KR20100122510A (ko) 중합체 파클리탁셀 접합체 및 암 치료 방법
EA032285B1 (ru) Прибор для инъекций с минимальным захватом и его использование
Murad et al. Image-guided convection-enhanced delivery of gemcitabine to the brainstem
Kofke et al. Alfentanil-induced hypermetabolism, seizure, and histopathology in rat brain
JP2005508375A (ja) Ｉｌ−１３を発現する腫瘍の選択的治療
KR20100062990A (ko) 국소적 약물전달을 위한 주사용 고분자-지질 배합물
CN108451930A (zh) 用于肿瘤毒性和mri的靶向可咯
JP2007501239A (ja) 放射線治療と組み合わせたｖｅｇｆアンタゴニストの使用
Levy et al. Transrectal ultrasound-guided intraprostatic injection of absolute ethanol with and without carmustine: a feasibility study in the canine model
US6753005B1 (en) Method for tissue perfusion
Singh et al. Volume of distribution and clearance of peptide-based nanofiber after convection-enhanced delivery
AU746153B2 (en) Method for tissue perfusion
US20230116621A1 (en) Drug delivery carrier including plga and beta-cyclodextrin containing drug
Takahashi et al. Enhancement of the cancer chemotherapeutic effect by anticancer agents in the form of fat emulsion
Platel et al. Preclinical evaluation of the cardiac toxicity of HMR-1826, a novel prodrug of doxorubicin
George et al. The production of tremor by cholinergic drugs: central sites of action
Schuster et al. Intraarterial therapy of human glioma xenografts in athymic rats using 4-hydroperoxycyclophosphamide
CN101808644A (zh) 聚合酶抑制剂及其用于治疗肿瘤的应用
CN114848577A (zh) 一种用于治疗皮下肿瘤的双层导电微针贴片及其制备方法和应用
JP2006501177A (ja) 遺伝子治療薬を送達する方法
Connelly et al. Stimulation of the caudal ventrolateral medulla decreases total lung resistance in dogs

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND FIRST INVENTOR S SURNAME TO READ: PIETRONIGRO